DHAOX®

Estudos Científicos

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term

 

 

Docosahexaenoic Acid Improves Endogen Antioxidant Defense in Arpe-19 Cells

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice

 

Supplementation of Re-Esterified Docosahexaenoic and Eicosapentaenoic Acids Reduce Inflammatory and Muscle Damage Markers after Exercise in Endurance Athletes: A Randomized, Controlled Crossover Trial

Oxidative Stress in Endurance Cycling Is Reduced Dose-Dependently after One Month of Re-Esterified DHA Supplementation

Effect of docosahexaenoic acid supplementation on differences of endurance exercise performance in competitive and non-competitive male cyclists

DHA- rich fish oil improves complex reaction time in female elite soccer players

Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study

Efecto dietético de la suplementación con DHA sobre la integridad del DNA espermático.

Efecto dietético de la suplementación con DHA sobre la integridad del DNA espermático.

Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial

The Effect of Oral Citicoline and Docosahexaenoic Acid on the Visual Field of Patients with Glaucoma: A Randomized Trial

Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids

Omega-3 fatty acid supplementation improves dry eye symptoms in patients with glaucoma: results of a prospective multicenter study

 

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease

Casos Clínicos de Blefaritis – Suplementados con Triglicérido de DHA

Monografía: Casos clínicos de sequedad ocular suplementados con triglicérido de DHA (Brudysec).

Monografía casos clínicos sequedad vaginal Brudygyne Dry.

Eficacia clínica de Brudyderm Dry Eye en las afecciones palpebrales por el uso de antiglaucomatosos.

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism

A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids

Ocular Surface and Tear Film Changes in Older Women Working with Computers

Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study

Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction

Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders

A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction

Oral supplementation with a nutraceutical formulation containing omega-3 fatty acids, vitamins, minerals, and antioxidants in a large series of patients with dry eye symptoms: results of a prospective study

Efficacy and safety study of an eyelid gel after repeated nocturnal application in healthy contact lens users and non-users

Suplementación dietética con ácido docosahexaenoico (DHA) triglicérido de alta concentración en niños y adolescentes con TDAH: ensayo aleatorizado doble ciego y controlado con placebo

Benefits of oral supplementation with docosahexaenoic acid and antioxidants in pseudoexfoliative glaucoma: a 6-month open-label randomized controlled trial

Efectos antioxidantes / antiinflamatorios de un suplemento a base de triglicéridos de DHA altamente concentrado: beneficios a corto, medio y largo plazo en los Estudios Clínicos Aleatorizados Oftalmológicos.

Establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health

Feasibility Study of a Docosahexaenoic Acid-Optimized Nutraceutical Formulation on the Macular Levels of Lutein in a Healthy Mediterranean Population

COMBINED INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA

THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA

Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: prospective controlled study of macular function by fundus microperimetry

 

Supplementation with high-content docosahexaenoic acid triglyceride in attentiondeficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Supplementation with high-content docosahexaenoic acid triglyceride in attentiondeficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Effects of docosahexanoic acid supplementation on inflammatory and subcutaneous adipose tissue gene expression in HIV-infected patients on combination antiretroviral therapy (cART). A sub-study of a randomized, double-blind, placebo-controlled study

 

Yosen
CNPJ: 29.456.226/0001-83

Os preços anunciados neste site ou via e-mail promocional podem ser alterados sem prévio aviso.
Formas de pagamento
*Para pagamentos com cartão de crédito, o pedido estará sujeito à aprovação da administradora do cartão. As informações contidas no cadastro são passíveis de confirmação, que poderá ser solicitada pela Yosen por e-mail.
Instagram Facebook-f Linkedin-in

+55 (16) 3315.9952 contato@yosen.com.br

SUPERA Parque de Inovação e Tecnologia
Av. Dra. Nadir Aguiar, 1.805, Ribeirão Preto - SP - Brasil CEP 14056-680

× Como posso te ajudar?